Evaluation of HLA-G 14 bp Ins/Del and +3142G>C Polymorphism with Susceptibility and Early Disease Activity in Rheumatoid Arthritis

Table 5

Association of HLA-G polymorphism in remitting and nonremitting RA patients.

Genotypes	Remitting patients; (%)	Nonremitting patients; (%)	OR (95% CI)
14-bp ins/del
Genotype
Ins/ins	1 (50.0)	1 (50.0)	1.00	—
Ins/del	10 (43.5)	13 (56.5)	0.76 (0.04–13.88)	0.897
Del/del	4 (80.0)	1 (20.0)	4.00 (0.12–137.10)	0.912
Allele
Ins	12 (40.0)	15 (50.0)	1.00	—
Del	18 (60.0)	15 (50.0)	1.50 (0.54–4.17)	0.602
+3142G>C
Genotype
GG	11 (45.8)	13 (54.2)	1.00	—
CG	4 (66.7)	2 (33.3)	2.36 (0.36–15.46)	0.651
CC	0 (0.0)	0 (0.0)	—	—
Allele
G	26 (63.4)	28 (65.1)	1.00	—
C	15 (36.6)	15 (34.9)	0.90 (0.38–2.14)	0.826